Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →
Help us improve your experience. Please confirm your investor type:
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
GNOG ETF · Global X Genomics & Biotechnology UCITS ETF
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -5.91%  | -3.22%  | +40.18%  | -8.55% | N/A | +1.24% | +1.24% | -2.77% | |
| Flows |
Key fund info
Enterprise
Similar ETFs
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -3.22% | +40.18% | -8.55% | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Exposure
Sustainability
ESG Consensus® by Conser
Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about GNOG ETF's sustainability, based on their methodology.
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
GNOG’s has a Final Sustainability Grade of either A+, A, or A-.
Replication
Issuer
| AuM | ||
|---|---|---|
PAVE | Global X U.S. Infrastructure Development ETF | €10.19B |
SHLD | Global X Defense Tech ETF | €7.33B |
QYLD | Global X Nasdaq 100 Covered Call ETF | €7.05B |
AIQ | Global X Artificial Intelligence & Technology ETF | €6.39B |
COPX | Global X Copper Miners ETF | €5.93B |
Frequently asked questions about GNOG
What does Global X Genomics & Biotechnology UCITS ETF, GNOG, invest in?
GNOG is a Passive ETF. This ETF provides exposure to Developed markets Equities.
Which benchmark or index does GNOG replicate?
GNOG tracks the Solactive Genomics v2 Index - USD, through a full replication replication method.
What is the Total Expense ratio (TER) of GNOG?
GNOG carries a total expense ratio (TER) of 0.5%, indicating the annual cost for holding the fund.
When was GNOG launched?
GNOG was introduced to the market on November 4, 2021. It trades on Spain, among other exchanges
Who is the ETF issuer of GNOG?
Global X Genomics & Biotechnology UCITS ETF, GNOG, is provided by Global X. Learn more about Global X here.
What is the current assets under management (AUM) of GNOG?
GNOG oversees €17M in assets as of April 2, 2026.
How has GNOG performed lately?
Based on data from April 2, 2026, GNOG returned -5.91% over the past month, -3.22% over the last three months and -2.77% year-to-date.
What are the latest inflows or outflows for GNOG?
As of April 2, 2026, GNOG recorded net flows of -€209K over the last month and +€921K year-to-date.
Does GNOG distribute dividends?
GNOG follows a capitalizing, meaning it reinvests income within the fund.
What are the main country or region exposures of GNOG?
As of February 28, 2026, GNOG has significant geographic allocations in USA, Switzerland and United Kingdom.
In which sector or theme does GNOG invest in?
As of February 28, 2026, GNOG focuses largely on Health Care.
How many securities does GNOG hold and how diversified is it?
As of February 28, 2026, GNOG holds 47 positions in its portfolio, with 62.49% of assets concentrated in its top 15 holdings.
What are the main positions in GNOG?
As of February 28, 2026, GNOG top three holdings include MODERNA INC, US74006W2070 and ARROWHEAD PHARMACEUTICALS INC.
What is the base currency of GNOG?
The base currency of GNOG is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
